BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8965738)

  • 1. [The health surveillance of personnel who handle antineoplastic agents].
    Forni A; Alessio L; Cortona G; Erba P; Feltrin G; Pesatori A
    Med Lav; 1996; 87(3):265-7. PubMed ID: 8965738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Health effects of occupational exposure to static magnetic fields used in magnetic resonance imaging: a review].
    Franco G; Perduri R; Murolo A
    Med Lav; 2008; 99(1):16-28. PubMed ID: 18254536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Documentation forms for monitoring occupational surveillance of healthcare workers who handle cytotoxic drugs.
    Parillo VL
    Oncol Nurs Forum; 1994; 21(1):115-20. PubMed ID: 8139995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the health protection and safety of workers exposed to antineoplastic drugs].
    Palazzo S; Bernardo G; Draicchio F; Lucchini R; Merlano M; Minguzzi M; Molinaro V; Scanni A; Sossai D; Villa L
    Med Lav; 1996; 87(3):255-64. PubMed ID: 8965737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytostatic drugs: occupational hazard to health care workers].
    Andrzejak R; Kucharski W; Mioduszewska J
    Med Pr; 1999; 50(1):61-5. PubMed ID: 10399719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathological effects due to antineoplastic drugs in workers engaged in their production, preparation or administration].
    Merler E; Villa L; Lucchini R
    Med Lav; 1996; 87(3):207-21. PubMed ID: 8965734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Summary of recommendations for a rational implementation of the ministry of health guidelines on the prevention of occupational risks in handling antineoplastic agents].
    Gruppo di Lavoro dell'Associazione Italiana di Medicina Preventiva dei Lavoratori della Sanità
    Med Lav; 2001; 92(2):137-48. PubMed ID: 11441591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical surveillance for antineoplastic-drug handlers.
    McDiarmid MA
    Am J Hosp Pharm; 1990 May; 47(5):1061-6. PubMed ID: 2337095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occupational risk in health care and research.
    Vecchio D; Sasco AJ; Cann CI
    Am J Ind Med; 2003 Apr; 43(4):369-97. PubMed ID: 12645094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Health effects of occupational exposure to cytostatics in medicinal personnel in the light of compulsory prophylactics: a cross-sectional study].
    Walusiak J; Wagrowska-Koski E; Pałczyński C
    Med Pr; 2003; 54(3):229-36. PubMed ID: 14669575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health surveillance for health care workers. A vital role for the occupational and environmental health nurse.
    Stone DS
    AAOHN J; 2000 Feb; 48(2):73-9. PubMed ID: 10865549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational exposure to tuberculosis--OSHA. Proposed rule and notice of public hearing.
    Fed Regist; 1997 Oct; 62(201):54160-308. PubMed ID: 10177300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hazards of chemotherapy. Implementing safe handling practices.
    Mayer DK
    Cancer; 1992 Aug; 70(4 Suppl):988-92. PubMed ID: 1638469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rules for prevention and certification of occupational diseases in workers occupationally exposed to antineoplastic drugs].
    Walusiak J; Wagrowska-Koski E; Pałczyński C
    Med Pr; 2001; 52(1):39-44. PubMed ID: 11424747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated comprehensive occupational surveillance system for health care workers.
    Dement JM; Pompeii LA; Østbye T; Epling C; Lipscomb HJ; James T; Jacobs MJ; Jackson G; Thomann W
    Am J Ind Med; 2004 Jun; 45(6):528-38. PubMed ID: 15164397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Health surveillance guidelines after the European directive on electromagnetic fields].
    Ottenga F; Giovanazzi A; Rossi L
    G Ital Med Lav Ergon; 2006; 28(3):248-51. PubMed ID: 17144411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Management of cytostatic drugs by nurses: analysis of preliminary results].
    Bilski B
    Med Pr; 2004; 55(3):243-7. PubMed ID: 15493499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mutagenic changes in medical personnel occupationally exposed to antineoplastic drugs].
    Milković-Kraus S
    Lijec Vjesn; 1992; 114(1-4):69-71. PubMed ID: 1343033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Health surveillance of workers with prior exposure to asbestos. Application in the metallurgy/metal mechanical field].
    Rivolta G; Della Foglia M; Donelli S; Riboldi L
    G Ital Med Lav Ergon; 2006; 28(2):169-72. PubMed ID: 16805450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nurses with dermal exposure to antineoplastic drugs: reproductive outcomes.
    Fransman W; Roeleveld N; Peelen S; de Kort W; Kromhout H; Heederik D
    Epidemiology; 2007 Jan; 18(1):112-9. PubMed ID: 17099323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.